CVS Health CVS Pharmacy & Consumer Wellness — D&A
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by CVS Health in its filing.
Tagged under the XBRL concept us-gaap:DepreciationDepletionAndAmortization.
The official record: CVS Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about CVS Health's pharmacy & consumer wellness — d&a.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is CVS Health's pharmacy & consumer wellness — D&A?
- CVS Health (CVS) reported pharmacy & consumer wellness — D&A of $406M in Q1 2026.
- How has CVS Health's pharmacy & consumer wellness — D&A changed year-over-year?
- CVS Health's pharmacy & consumer wellness — D&A increased by 5.7% year-over-year, from $384M to $406M.
- What is the long-term trend for CVS Health's pharmacy & consumer wellness — D&A?
- Over 4 years (2021 to 2025), CVS Health's pharmacy & consumer wellness — D&A has grown at a -5.3% compound annual growth rate (CAGR), from $1.96B to $1.57B.
- What does pharmacy & consumer wellness — D&A mean?
- This metric represents the non-cash expense allocated to the pharmacy and consumer wellness segment for the wear and tear of physical assets and the amortization of intangible assets like acquired customer relationships or brand value. It reflects the capital intensity of the segment's operations, including investments in retail store infrastructure and technology. Tracking this helps assess the segment's ongoing capital expenditure requirements and asset lifecycle management.